Aurora kinases: Therapeutic potential

Drugs of the Future

Volumn 30, Issue 1, 2005, Pages 29-37

  Montembault, Emilie ^a   Prigent, Claude ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; AURORA A KINASE; AURORA B KINASE; AURORA C KINASE; AURORA KINASE; AURORA KINASE INHIBITOR; AZD 1152; CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE; HESPERADIN; N [4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY) 4 QUINAZOLINYLAMINO]PHENYL]BENZAMIDE; PACLITAXEL; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

BINDING SITE; CANCER; CANCER TRANSPLANTATION; CELL STRAIN 3T3; CELL TRANSFORMATION; DRUG DESIGN; DRUG TARGETING; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; MITOSIS; NONHUMAN; PROTEIN FAMILY; REVIEW; TUMOR CELL;

EID: 14944338969     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2005.030.01.875304     Document Type: Review

References (61)

1. Bischoff, J.R., Plowman, G.D. The Aurora/lpl1p kinase family: Regulators of chromosome segregation and cytokinesis. Trends Cell Biol 1999, 9(11): 454-9.
2. Nigg, E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001, 2(1): 21-32.
3. Kimura, M. et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast lpl1. J Biol Chem 1997, 272(21): 13766-71.
4. Glover, D.M. et al. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 1995, 81(1): 95-105.
5. Bischoff, J.R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998, 17(11): 3052-65.
6. Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998, 20(2): 189-93.
7. Anand, S. et al. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003, 3(1): 51-62.
8. Zhang, D. et al. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 2004, 23(54): 8720-30.
9. Adams, R.R. et al. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001, 11(2): 49-54.
10. Zeitlin, S.G. et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J Cell Biol 2001, 155(7): 1147-57.
11. Lan, W. et al. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol 2004, 14(4): 273-86.
12. Tatsuka, M. et al. Multinuclearity and increased ploidy caused by overexpression of the aurora- and lpl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 1998, 58(21): 4811-6.
13. Terada, Y. et al. AIM-1: A mammalian midbody-associated protein required for cytokinesis. EMBO J 1998, 17(3): 667-76.
14. Dulyaninova, N.G., Bresnick, A.R. The long myosin light chain kinase is differentially phosphorylated during interphase and mitosis. Exp Cell Res 2004, 299(2): 303-14.
15. Kimura, M. et al. Cell cycle-dependent expression and centrosome localization of a third human aurora/lpl1-related protein kinase, AIK3. J Biol Chem 1999, 274(11): 7334-40.
16. Li, X. et al. Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C. J Biol Chem 2004, 279(45): 47201-11.
17. Sasai, K. et al. Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil Cytoskeleton 2004, 59(4): 249-63.
18. Jallepalli, P.V., Lengauer, C. Chromosome segregation and cancer: Cutting through the mystery. Nat Rev Cancer 2001, 1 (2): 109-17.
19. Saunders, W.S. et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 2000, 97(1): 303-8.
20. Sato, N. et al. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet Cytogenet 2001, 126(1): 13-9.
21. Pihan, G.A. et al. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003, 63(6): 1398-404.
22. Lengauer, C. et al. Genetic instability in colorectal cancers. Nature 1997, 386(6625): 623-7.
23. Gisselsson, D. et al. Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer 2002, 87(2): 202-7.
24. Duensing, S. et al. Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitfs lymphoma. Mol Cancer 2003, 2(1): 30.
25. Kramer, A. et al. Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia 2003, 17(11): 2207-13.
26. Boveri, T. Zur Frage der Entsehung Maligner Tumoren. Fischer, Jena, 1914.
27. Tanner, M.M. et al. Amplification of chromosomal region 20q13 in invasive breast cancer: Prognostic implications. Clin Cancer Res 1995, 1(12): 1455-61.
28. Muleris, M. et al. Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors. Cancer Genet Cytogenet 1987, 29(2): 289-301.
29. Reznikoff, C.A. et al. A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 1996, 23(5): 571-84.
30. Courjal, F. et al. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer 1996, 74(12): 1984-9.
31. Sen, S. et al. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997, 14(18): 2195-200.
32. Ota, T. et al. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res 2002, 62(18): 5168-77.
33. Tanaka, T. et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999, 59(9): 2041-4.
34. Tanner, M.M. et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000, 6(5): 1833-9.
35. Gritsko, T.M. et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003, 9(4): 1420-6.
36. Li, D. et al. Overexpression of oncogenic STK15/BTAK/ Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003, 9(3): 991-7.
37. Jeng, Y.M. et al. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004, 10(6): 2065-71.
38. Cremet, J.Y. et al. Preparation and characterization of a human aurora-A kinase monoclonal antibody. Mol Cell Biochem 2003, 243(1-2): 123-31.
39. Murnion, M.E. et al. Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. J Biol Chem 2001, 276(28): 26656-65.
40. Walter, A.O. et al. The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene 2000, 19(42): 4906-16.
41. Hauf, S. et al. The small molecule hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003, 161(2): 281-94.
42. Ditchfield, C. et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 2003, 161(2): 267-80.
43. Harrington, E.A. et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004, 10(3): 262-7.
44. Doggrell, S.A. Dawn of Aurora kinase inhibitors as anticancer drugs. Expert Opin Invest Drugs 2004, 13(9): 1199-201.
45. Cheetham, G.M. et al. Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J Biol Chem 2002, 277(45): 42419-22.
46. Nair, J.S. et al. A novel Aurora B kinase inhibitor with potent anticancer activity either as a single agent or in combination with chemotherapy. J Clin Oncol 2004, 22(14S): 9568.
47. Bayliss, R. et al. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol Cell 2003, 12(4): 851-62.
48. Hirota, T. et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 2003, 114(5): 585-98.
49. Adams, R.R. et al. Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J Cell Biol 2001, 153(4): 865-80.
50. Yasui, Y. et al. Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis. J Biol Chem 2004, 279(13): 12997-3003.
51. Chen, J. et al. Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells. J Biol Chem 2003, 278(1): 486-90.
52. Tanaka, M. et al. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 2002, 277(12): 10719-26.
53. Kimura, M. et al. Cell cycle-dependent regulation of the human aurora B promoter. Biochem Biophys Res Commun 2004, 316(3): 930-6.
54. Pierce, A.M. et al. Differential activities of E2F family members: Unique functions in regulating transcription. Mol Carcinogen 1998, 22(3): 190-8.
55. Kallioniemi, A. et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994, 91(6): 2156-60.
56. Guan, X.Y. et al. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 1994, 8(2): 155-61.
57. James, L.A. et al. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: Identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 1997, 14(9): 1059-65.
58. Isola, J.J. et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995, 147(4): 905-11.
59. Tanner, M.M. et al. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 1996, 56(15): 3441-5.
60. Takahashi, T. et al. Centrosomal kinases, HsAIRK1 and HsAIRK3, are overexpressed in primary colorectal cancers. Jpn J Cancer Res 2000, 91 (10): 1007-14.
61. Katayama, H. et al. Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst 1999, 91(13): 1160-2.